spacer
home > pmps > summer 2007 > the therapeutics of injections
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Therapeutics of Injections

Kevin Maynard, Business Development Director at Imprint Pharmaceuticals Ltd, investigates the solublisation and recovery of injectable pharmaceutical materials, and the importance of usability and safety for end users

Many injectable drugs need to be reconstituted either at home or in the clinic. Special devices have been developed to improve the reproducibility, simplicity and safety of the reconstitution of these therapies for end users, including healthcare workers and patients.

Pharmaceutical companies are becoming ever more successful in bringing the fruits of the human genome project to market. Treatment of diseases such as cancer, rheumatoid arthritis, Crohn’s disease and diabetes are being transformed by these therapies. However, many of the therapies require injection and, hence, come with all the complications, both technical and presentational, that injectable therapies bring.

Many of these therapies require frequent injections; depending on the nature of the disease and the patient’s individual condition, those injections could be weekly, daily, or even more frequent.

Many injectable therapeutics are stored as powders; they are more stable in this form. Therapeutics stored as a powder need to be solublised with a liquid diluent and transferred to an injection device before being injected, resulting in an additional operation for untrained users to carry out. This step can be quite complex, with multiple variants in the reconstitution process depending on the therapy, the delivery device and the user’s setting and knowledge. This creates significant issues for those unaware of the problem.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kevin Maynard is the Business Development Director of Imprint Pharmaceuticals Ltd, a company focused on providing solutions to the reconstitution and delivery of complex formulations. Over the last 10 years, Kevin has concentrated his efforts on providing clients with practical technology to solve some of the most intractable problems in managing complex fluids at the bedside or clinic. He has a PhD in Pharmacology and 20 years’ experience in drug delivery, cancer biology and therapeutic formulations.
spacer
Kevin Maynard
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Optimizing pharmaceutical processes

An increase in requirements from regulatory agencies around the world, combined with a growing demand for drugs in prefilled injections systems – a trend that industry experts have projected will continue – has led pharmaceutical and biotech supply chains to gain in significance. Well established and optimized processes are crucial for offering uninterrupted market supply. To satisfy its customers a CDMO must foster flexibility, efficiency and safety throughout the entire supply chain. The most important goal for all parties involved in the bio-pharma business is maximization of product quality where even small decisions can make a big difference. Future-oriented pharma processes can add value to any compound.
More info >>

White Papers

Life Cycle of an Analytical Method - a Case Study on the Monocyte Activation Test

Wickham Laboratories Limited

Pyrogens, a heterogeneous group of fever inducing contaminants, are comprised of microbial and non-microbial compounds; e.g. endotoxin (lipopolysaccharide, LPS) produced by Gram-negative bacteria, lipoteichoic acid (LTA) from Gram-positive bacteria, bacterial DNA (CpG-motive), endogenous pyrogens, virus and fungi particles or even fragments of packaging materials, plastic and dust. Contaminat ion wi th pyrogens in pharmaceutical products, biotherapeutics and on medical devices can lead to life threatening fever reactions. To ensure consumer safety, pyrogen testing is mandatory for parenteral products and medical devices.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement